Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Clinical trials

Outside the Lab Metabolism & Diabetes

Trimming the Fat

| Roisin McGuigan

Could weight management replace medication as the first line treatment for type II diabetes?

Tools & Techniques Microbiology

Benchmarking the Microbiome

| Roisin McGuigan

What does analysis of the microbiome literature tell us about priorities and progress in the field?

Research Field Clinical trials

Trials and Tribulations

| Roisin McGuigan

If prospective registration is enforced for clinical trials, questionable results become easier to spot

Research Field Drug delivery

Recognizing Friend from Foe

| Werner Cautreels

Solutions are needed to teach the immune system to recognize biological drugs as partners, not plunderers.

Tools & Techniques Analytical science

Writing off Cancer

| Joanna Cummings

When it comes to identifying cancerous tissue, is the “MasSpec Pen” mightier than the sword?

Outside the Lab Clinical trials

Too Pregnant to Participate

| Roisin McGuigan

Are current ethical guidelines for clinical studies letting pregnant women down?

Research Field Clinical trials

From Acne to MS

| Roisin McGuigan

A recent clinical trial finds a new use for an old antibiotic.

Tools & Techniques Cancer

Getting Smart with Clinical Trials

| Joy Yucaitis

Liquid biopsy technology could help boost clinical trial success.

Tools & Techniques Cell & gene therapy

Stem Cell Stepping Stones

| Roisin McGuigan

A new treatment for STAT1 mutations has a disappointingly low success rate – but shows potential.

Research Field Clinical trials

Reuse, Recycle, Regenerate

| Roisin McGuigan

Two repurposed drugs prevent neurodegeneration in mice – and both are already in clinical use.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register